Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of 6 % Hydroxyethyl Starch 130/0.4 (Voluven®) vs. 5% HSA in Volume Replacement Therapy During Elective Open-heart Surgery in Paediatric Patients

NCT00860405 is registered in ClinicalTrials.gov with Fresenius Kabi as lead sponsor.

NCT NCT00860405
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00860405 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of 6 % Hydroxyethyl Starch 130/0.4 (Voluven®) vs. 5% HSA in Volume Replacement Therapy During Elective Open-heart Surgery in Paediatric Patients
Lead sponsor
Fresenius Kabi
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2009
Completion date
December 31, 2010
Enrollment
61 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac surgery, cardiopulmonary bypass